Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized, Double-blind, Placebo-controlled Parallel Group Study of the Efficacy of Octreotide in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery

NCT02437825 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT02437825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02437825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized, Double-blind, Placebo-controlled Parallel Group Study of the Efficacy of Octreotide in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery
Lead sponsor
Hadassah Medical Organization
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2015
Completion date
June 30, 2021
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fistula; salivary duct or gland